The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

Share Price Information for Clean Power Hyd (CPH2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.25
Bid: 12.00
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 0.50 (4.167%)
Open: 12.25
High: 12.25
Low: 12.25
Prev. Close: 12.25
CPH2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Manufacturing Agreement with Fabrum Solutions Ltd

31 Jan 2023 07:00

RNS Number : 3251O
Clean Power Hydrogen
31 January 2023
 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

31 January 2023

 

Clean Power Hydrogen Plc

("CPH2", the "Company" or the "Group")

 

Manufacturing Agreement with Fabrum Solutions Ltd

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce that it has executed a manufacturing agreement with New Zealand based Fabrum Solutions Ltd ("Fabrum") (the "Agreement"), one of the world's leading cryogenic systems manufacturers for gas separation and hydrogen liquefaction. Fabrum is the result of the merger between Fabrum Solutions and AFCryo, the Company's supplier of the cryogenic systems since 2020.

 

Highlights:

· Pursuant to the terms of the Agreement, Fabrum will have the right to manufacture MFE220 units in New Zealand on a non-exclusive basis.

· In addition, CPH2 has granted Fabrum a non-exclusive license to sell CPH2 products in New Zealand and Australia whereby CPH2 will receive a technology fee per unit.

· CPH2 can order units to be produced by Fabrum in New Zealand and Australia for new and existing CPH2 customers, with cost and profit-sharing arrangements for such orders included in the Agreement.

· First MFE220 container already shipped to Fabrum's facility in New Zealand for completion and commissioning.

 

The Agreement, which will be effective for a period of ten years, will allow an acceleration of the roll out of the Company's technology across Australia and New Zealand as the market for hydrogen grows rapidly. The Agreement, which is CPH2's first in the region, aligns with CPH2's objectives to license out manufacturing of the MFE220 to accelerate the delivery of the technology to an ever-growing market.

 

The Agreement strengthens the working and strategic relationship between the two companies possessing symbotic, patented technologies which advance Membrane Free Electrolysers. CPH2 has already shipped the first MFE220 to Fabrum's facilities in New Zealand where it will completed and fitted out with the remaining components and commissioned for use.

 

In December 2022, it was announced that CPH2 and Fabrum had executed a development agreement for the purposes of the technical development of CPH2's MFE. Under the terms of this agreement, Fabrum has been working with CPH2 and its existing industry partner Kenera Energy Solutions ("Kenera"), to provide engineering expertise in support of design reviews, systems documentation and safety cases. CPH2 has also executed a deed of variation to its existing supply agreement with Fabrum to allow it to purchase DPWG Cryocoolers for embedding in its MFE products on an exclusive basis. 

 

CPH2 is committed to its strategic target of 4GW MFE annual production by 2030; of this 1GW will be in-house manufacturing and assembly and 3GW will be via license agreements such as that agreed with Fabrum. Interest in CPH2's innovative and disruptive hydrogen electrolyser technology continues to grow and our agreement with Fabrum will allow for faster scale up and market penetration in Australia and New Zealand.

 

Jon Duffy, Chief Executive Officer of CPH2, commented:

 

"I am delighted to extend our working relationship with Fabrum, the world leaders in cryogenic systems and hydrogen liquefaction through the manufacturing and licensing deal. The collaboration between CPH2 and Fabrum will allow for CPH2's MFE technology to be used across Australia and New Zealand, where the green hydrogen sector is rapidly developing. We look forward to continuing working with the team at Fabrum in the future."

 

Christopher Boyle, Managing Director of Fabrum, commented:

 

"We see the CPH2 technology as a world beating, low-cost solution to the production of green hydrogen, which is why we are adding to our development agreement with CPH2 with a full-scale manufacturing agreement. We are excited to be able to offer CPH2's world leading MFE technology across New Zealand and Australia. We have been experiencing strong demand for hydrogen solutions across various industries in this part of the world. Our close partnership with CPH2 will enable delivery of such solutions at a faster pace."

 

For more information, please contact:

 

Clean Power Hydrogen Plc

via Camarco

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer

Cenkos Securities plc - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

Camarco PR

+ 44(0) 20 3 757 4980

Billy Clegg

Owen Roberts

Lily Pettifar

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

Overview of Fabrum

Fabrum is headquartered in Christchurch, New Zealand and leads the world in industrialized small to medium scale liquefaction systems and composite cryogenic vessels.

The company is actively deploying end to end liquid hydrogen solutions globally across heavy transport, mining and aviation markets. Core competencies include green hydrogen production, storage, dispensing and system integration.

Fabrum also has a strong presence in the traditional cryogenic markets of liquid nitrogen (LIN), liquid oxygen (LOX), LNG and Liquid Air (LAIR) with customers ranging from Animal husbandry, Hi-tech research institutions, Manufacturing and Defense forces.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAEFEDEPDEAA
12
Date   Source Headline
19th Apr 20247:00 amRNS2023 Full Year Results
23rd Feb 20247:00 amRNSAwards under Long-Term Incentive Plan
21st Feb 20247:00 amRNSOperational Update
5th Feb 20247:00 amRNSISO Certifications
28th Nov 20237:00 amRNSRevised Agreement with ATOME Energy
20th Nov 20237:00 amRNSChange of Nominated Adviser
2nd Nov 20237:00 amRNSCompany Update
21st Sep 20237:00 amRNSInterim Results
22nd Jun 20237:00 amRNS2023 Save As You Earn Scheme
21st Jun 20231:09 pmRNSResult of AGM
19th Jun 20237:00 amRNSGrant of EMI Options
6th Jun 20237:00 amRNSUpdate on Licence Agreement with GHFG Limited
17th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
28th Apr 202312:16 pmRNSHoldings in Company
26th Apr 20233:26 pmRNSPDMR Dealing
25th Apr 20237:00 amRNSCorporate Presentation
20th Apr 20237:00 amRNSMaiden Financial Results
13th Apr 20237:00 amRNSInvestor Presentation
27th Mar 20237:00 amRNSFabrum Solutions Ltd receives order from Obayashi
16th Mar 20237:00 amRNSPDMR Dealing
27th Feb 20237:00 amRNSLock-in Agreement Extension
8th Feb 20237:00 amRNSSave As You Earn Scheme
31st Jan 20237:00 amRNSManufacturing Agreement with Fabrum Solutions Ltd
26th Jan 20237:00 amRNSAppointment of Chief Technical Officer
22nd Dec 20227:00 amRNSAgreements Signed with Fabrum Solutions Ltd
20th Dec 20221:14 pmRNSHolding(s) in Company
12th Dec 20225:14 pmRNSInvestment in ATOME Energy plc
6th Dec 20227:00 amRNSSenior Management Team Strengthened
22nd Nov 202211:06 amRNSSecond Price Monitoring Extn
22nd Nov 202211:00 amRNSPrice Monitoring Extension
22nd Nov 20229:00 amRNSPrice Monitoring Extension
22nd Nov 20227:00 amRNSOperational Update
4th Oct 20224:41 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSInterim results
23rd Sep 20227:00 amRNSInterim results
7th Sep 20224:45 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSAppointment of James Hobson as CFO
5th Sep 20227:00 amRNSAgreement with KCA Deutag Group
24th Aug 20228:11 amRNSOperational Update
19th Jul 20225:55 pmRNSResult of AGM
19th Jul 20227:45 amRNSLicence Agreement with GHFG Ltd.
23rd Jun 20225:24 pmRNSNotice of 2022 Annual General Meeting
27th May 20227:00 amRNSGroup Annual Report and Financial Statements
29th Apr 202210:16 amRNSOperations Update
4th Apr 202212:15 pmRNSAdditional purchase order from existing customer
21st Mar 20227:00 amRNSNew purchase order from additional customer
21st Mar 20227:00 amRNSOperations Update
2nd Mar 20225:31 pmRNSHolding(s) in Company
1st Mar 20224:41 pmRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.